You are here
- Home
- Diseases & Conditions
- All Diseases and Conditions
A randomised, double-blind, placebo and active controlled, multi-centre, 6 way cross-over, single-dose Phase IIa study to investigate the local and systemic effects of 3 different doses of inhaled AZD2115 in patients with chronic obstructive pulmonary disease (COPD)
- Disease
- chronic obstructive pulmonary disease
- Generic Name
- AZD2115
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- II
- Start Date
- Jan 18, 1971
- Study Name
- D3060C00003
- Study Id
- D3060C00003
- ClinicalTrials.gov ID
- NCT01498081
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
